{
    "id": 886,
    "shortName": "tbmanagement",
    "name": "Global Tuberculosis (TB) Clinical Management and Research",
    "language": "en",
    "shortDescription": "Health Care Workers and Health Professions Students can prepare to plan and deliver TB care in their communities by applying the latest clinical and research data presented in this nine-week course focusing on TB\/HIV Co-Infection.",
    "aboutTheCourse": "<p><b>ENROLLMENT OPTIONS<\/b>\n<\/p>\n\n<p>Those interested in participating in this course have three options:\n<\/p>\n\n<ol>\n    <li><b>Free\nEnrollment: <\/b> Click “Sign Up” to enroll in course for FREE and earn a statement of accomplishment upon completion.\n    <\/li>\n    <li><b>Signature\nTrack Enrollment: <\/b> Click “Signature Track” and follow the enrollment steps.  You will be required to pay a $39 non-refundable fee.  Upon course completion you will receive a verified certificate, which employers can search. <a href=\"http:\/\/help.coursera.org\/customer\/portal\/articles\/1167998-what-is-a-verified-certificate-how-can-i-use-it-\">What’s\nthis?<\/a>\n    <\/li>\n    <li><b>Continuing\nNursing Education (CNE) Credit:<\/b>  For healthcare professionals interested in earning Continuing Nurse Education (CNE) contact hours you must:<\/li>\n<\/ol>\n\n\n\n\n\n<p><\/p>\n<ul>\n    <li>Complete Signature Track enrollment.\n        <br>\n    <\/li>\n    <li>Complete registration process through Johns Hopkins University School of Nursing. You will be required to pay an additional non-refundable fee of $60 in addition to the $39 fee for signature track.\n        <br>\n    <\/li>\n<\/ul>\n<p><\/p>\n\n\n\n<p><b>SIGNING UP FOR CNE\nCREDIT<\/b>\n<\/p>\n\n<p><\/p>\n<p>If you’re interested in signing up for CNE Credit and have already signed up for Signature Track, click this link to register for CNE: <a href=\"http:\/\/nursing.jhu.edu\/tbmanagement\" target=\"_blank\" title=\"Link: http:\/\/nursing.jhu.edu\/tbmanagement\">http:\/\/nursing.jhu.edu\/tbmanagement<\/a>\n<\/p>\n<p><b>ABOUT THE COURSE<\/b>\n<\/p>\n<p><span>Estimates from the World Health Organization demonstrate that\nMycobacterium tuberculosis (TB) remains a leading cause of death globally. TB also\nis the leading cause of death among persons with HIV infection and remains a\nchallenge for both clinicians and researchers. \nThis nine-week course focuses on TB\/HIV Co-Infection and innovative\nresearch solutions to address the disease and introduces an overview on TB Care\nand Management Health Care Workers or Health Profession Students will learn to plan\nand deliver TB care in their communities by applying the latest clinical and\nresearch data to their setting. <br>\n<br>\nCourse consists of:<\/span>\n<\/p>\n\n<p><\/p>\n<ul>\n    <li>Video lectures\n        <br>\n    <\/li>\n    <li>Quizzes\n        <br>\n    <\/li>\n    <li>Peer assessments\n        <br>\n    <\/li>\n    <li>Large and small group online work and discussions\n        <br>\n    <\/li>\n    <li>Individual work\n        <br>\n    <\/li>\n    <li>Access to world renowned TB and HIV experts\n        <br>\n    <\/li>\n<\/ul>\n<p><\/p>\n\n\n\n\n\n\n\n\n\n\n\n<p><b>Course Competencies <\/b><span><br>\n<br><\/span>\n<\/p>\n<ul>\n    <li>At the end of the course, it is expected that participants will be able to:\n        <br>\n    <\/li>\n    <li>Describe the epidemiology of TB and drug resistant TB in patients with and without HIV\n        <br>\n    <\/li>\n    <li>Diagnose TB infection accurately and understand the latest diagnostic advances\n        <br>\n    <\/li>\n    <li>Identify correct treatment regimens for TB, MDR-TB and XDR-TB management\n        <br>\n    <\/li>\n    <li>Manage clients presenting with all forms of TB including those co-infected with HIV\n        <br>\n    <\/li>\n    <li>Recognize and manage all adverse reaction associated with antiretroviral and TB treatment\n        <br>\n    <\/li>\n    <li>Identify strategies to assist clients and patients in improving treatment adherence\n        <br>\n    <\/li>\n<\/ul>\n<p><\/p>",
    "targetAudience": 1,
    "courseSyllabus": "<b>Week 1: Epidemiologic Overview of Global TB and DR-TB\n\n    <\/b><br><ul><li>Global TB Epidemiology\n    <\/li><li>Drug Resistant Tuberculosis\n   \n\n<\/li><\/ul><br><b>Week 2: Diagnostic Testing for TB\n<\/b><br><ul><li>Current Approaches to TB Diagnosis\n    <\/li><li>Emerging Tools in TB Diagnosis&nbsp;\n<\/li><\/ul><br><b>Week 3: Pharmacology of Anti-Tuberculosis Treatment\n<\/b><br><ul><li>Treatment of Tuberculosis I: Current Therapeutics\n    <\/li><li>Treatment of Tuberculosis II: Areas of Research\n    <\/li><\/ul><br><b>Week 4: Overview of TB Management Principles\n<\/b><br><ul><li>Principles of Clinical Management of TB\n    <\/li><li>Video 3: Challenges and Knowledge Gaps in TB\n    <\/li><\/ul><br><b>Week 5: Latent TB in India\n<\/b><br><ul><li>Latent TB in India\n    <\/li><li>Example Research Solutions for India\n    <\/li><\/ul><br><b>Week 6: TB Infection Control in South Africa\n<\/b><br><ul><li>TB Infection Control\n<\/li><li>Systematic Evaluation of Infection Control at Primary Health Centers and M(X)DR-TB Hospitals in South Africa\n    <\/li><\/ul><br><b>Week 7:TB in Healthcare Workers<\/b><br><ul><li>TB in Healthcare Workers Globally\n    <\/li><li>Example Research Solutions from around the World&nbsp;\n<\/li><\/ul><br><b>Week 8: TB Intensified Case Finding in Brazil\n<\/b><br><ul><li>TB Intensified Case Findings in Brazil\n    <\/li><li>Solutions for Brazil\n    <\/li><\/ul><br><b>Week 9: Cost Effectiveness Analysis in TB Clinical Trials\n<\/b><br><ul><li>Cost Effectiveness Analysis in TB Clinical Trials\n    <\/li><li>Cost Effectiveness TB Research Example <\/li><\/ul>",
    "estimatedClassWorkload": "2-4 hours\/week",
    "recommendedBackground": "",
    "links": {

    }
}